Novo Nordisk A/S (NVO)

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $244.96 billion as of September 11, 2025. Its market cap has decreased by -60.32% in one year.

• Market Cap: 244.96B
• Enterprise Value: 257.57B
• 1-Year Change: -60.32%
• Ranking: #46
• Category: Mega-Cap
• Stock Price: $54.37

Market Cap Chart

Since December 1, 1998, Novo Nordisk's market cap has increased from $5.15B to $244.96B, an increase of 4,651.90%. That is a compound annual growth rate of 15.50%.

Market Cap History

Date	Market Cap	% Change
Sep 9, 2025	242.45B	-37.50%
Dec 31, 2024	387.95B	-17.76%
Dec 29, 2023	471.73B	54.12%
Dec 30, 2022	306.08B	19.24%
Dec 31, 2021	256.69B	55.86%
Dec 31, 2020	164.70B	16.14%
Dec 31, 2019	141.81B	23.12%
Dec 31, 2018	115.18B	-15.84%
Dec 29, 2017	136.86B	46.79%
Dec 30, 2016	93.24B	-38.18%
Dec 31, 2015	150.82B	29.59%
Dec 31, 2014	116.38B	12.48%
Dec 31, 2013	103.47B	9.30%
Dec 31, 2012	94.66B	36.88%
Dec 30, 2011	69.16B	-0.91%
Dec 31, 2010	69.79B	72.41%
Dec 31, 2009	40.48B	26.82%
Dec 31, 2008	31.92B	-22.43%
Dec 31, 2007	41.15B	52.03%
Dec 29, 2006	27.07B	44.82%
Dec 30, 2005	18.69B	1.87%
Dec 31, 2004	18.35B	29.73%
Dec 31, 2003	14.14B	41.73%
Dec 31, 2002	9.98B	25.01%
Dec 29, 2000	7.98B	36.89%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	669.62B
Johnson & Johnson	426.42B
AbbVie	370.50B
UnitedHealth Group	315.08B
AstraZeneca	251.37B
Novartis AG	249.66B
Abbott Laboratories	229.46B
Merck & Co.	211.01B